The FDA has accepted an investigational new drug application for an investigational and proprietary combination therapy to ...
AudioEye reports that in 2026, digital accessibility is mandatory for all online organizations, highlighting key laws and ...
SOURCE MUSIC, the label behind K-pop girl group LE SSERAFIM, is inviting aspiring male artists from the Philippines and ...
Despite 700% net product revenue growth to $113 million, ImmunityBio's high debt load and unprofitability remain significant ...
Discover the essential benefits of Vitamin C serum and follow our step-by-step application guide for summer. Learn how this ...
According to Towards FnB, the global bread improvers market size is evaluated at USD 1.70 billion in 2026 and is projected to reach USD 2.92 billion by 2035, reflecting a robust CAGR of 6.2% from 2026 ...
Travere Therapeutics FY25 sales surged on Filspari, but the FDA FSGS label decision was delayed to April. Click here to read ...
The Abu Dhabi Chamber of Commerce and Industry has honoured a number of leading companies that have been awarded the ...
Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company focused on ...
Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...
IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced ...
Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trialCompass continues to advance commercial preparations to be launch-ready by ...